Testing effectiveness (Phase 2)Study completedNCT02919501
What this trial is testing
Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
Who this might be right for
Depressive Disorder, Major
H. Lundbeck A/S 55